Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Most promising clinical uses for stem cells from fat agreed on by international society

06.10.2004


While questions still remain about the nature and function of stem cells found in fat, a group of researchers and clinicians convened today in Pittsburgh at the Second Annual Meeting of the International Fat Applied Technology Society (IFATS) agreed that research should move forward with the ultimate goal of performing human clinical trials to test the cells’ therapeutic potential for specific indications.



Today concludes scientific sessions exploring how adipose tissue, or fat, can be an abundant source of stem cells that could be used for tissue engineering and regenerative medicine. An important outcome of the meeting was the development of a consensus defining key scientific questions for future study and determining the field’s most promising clinical applications.

More than 300,000 liposuction procedures are performed in the United States each year, producing about 150,000 gallons of fat that is normally discarded. In 2001, researchers first reported that such tissue contained stem cells, and since then, additional studies have suggested they can be coaxed into other cell types, such as nerve, bone, muscle and blood vessels; or it may be that they have properties of these cells. Some research has progressed more rapidly, with animal studies indicating potential for the development of treatments for heart attack or bone injury, for example, while results looking at other uses are still quite preliminary.


There are currently no human trials in the United States evaluating the potential of stem cells derived from fat, but in reaching consensus on the most promising clinical applications, those attending the IFATS meeting believe the first clinical attempts in patients should be for repairing or healing bone defects, promoting growth of blood vessels in tissues not receiving sufficient blood supply, and for treating acute or chronic cardiac and peripheral vascular diseases.

Moreover, the group felt the best use of the technology should be to develop therapies using patients’ own cells, as opposed to cells that might be donated by other individuals. Because adipose is both abundantly available and easily accessible, it offers a practical source of stem cells.

A key question the group answered was simply what to call the cells, with the decision in favor of the term adipose-derived stem cells, even though it also was agreed that these cells are most likely comprised of multiple cell populations – some that are capable of proliferation and differentiation and other groups consisting of mature cells. The society aims to develop common scientific methods in order to best compare results between studies, and believes that much of the research effort should be directed toward identifying the protein markers for adipose stem cells in order to better understand how they differentiate into other cell types and what factors they secrete.

In developing its consensus, the society focused on three main areas, with separate sessions addressing each. Leading discussions that addressed the biology of the cells was Patricia Zuk, Ph.D., research director, Regenerative Bioengineering and Repair Lab, at the David Geffen School of Medicine, University of California, Los Angeles. The session focusing on scientific methods was led by Jeffrey Gimble, M.D., Ph.D., a professor at the Pennington Biomedical Research Center at Louisiana State University. Discussions on clinical applications and opportunities were moderated by Keith March, M.D., Ph.D., director of the Indiana Center for Vascular Biology and Medicine and professor of medicine at the Indiana University School of Medicine.

Lisa Rossi | EurekAlert!
Further information:
http://www.upmc.edu

More articles from Life Sciences:

nachricht Tag it EASI – a new method for accurate protein analysis
20.06.2018 | Max-Planck-Institut für Biochemie

nachricht How to track and trace a protein: Nanosensors monitor intracellular deliveries
19.06.2018 | Universität Basel

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Temperature-controlled fiber-optic light source with liquid core

In a recent publication in the renowned journal Optica, scientists of Leibniz-Institute of Photonic Technology (Leibniz IPHT) in Jena showed that they can accurately control the optical properties of liquid-core fiber lasers and therefore their spectral band width by temperature and pressure tuning.

Already last year, the researchers provided experimental proof of a new dynamic of hybrid solitons– temporally and spectrally stationary light waves resulting...

Im Focus: Overdosing on Calcium

Nano crystals impact stem cell fate during bone formation

Scientists from the University of Freiburg and the University of Basel identified a master regulator for bone regeneration. Prasad Shastri, Professor of...

Im Focus: AchemAsia 2019 will take place in Shanghai

Moving into its fourth decade, AchemAsia is setting out for new horizons: The International Expo and Innovation Forum for Sustainable Chemical Production will take place from 21-23 May 2019 in Shanghai, China. With an updated event profile, the eleventh edition focusses on topics that are especially relevant for the Chinese process industry, putting a strong emphasis on sustainability and innovation.

Founded in 1989 as a spin-off of ACHEMA to cater to the needs of China’s then developing industry, AchemAsia has since grown into a platform where the latest...

Im Focus: First real-time test of Li-Fi utilization for the industrial Internet of Things

The BMBF-funded OWICELLS project was successfully completed with a final presentation at the BMW plant in Munich. The presentation demonstrated a Li-Fi communication with a mobile robot, while the robot carried out usual production processes (welding, moving and testing parts) in a 5x5m² production cell. The robust, optical wireless transmission is based on spatial diversity; in other words, data is sent and received simultaneously by several LEDs and several photodiodes. The system can transmit data at more than 100 Mbit/s and five milliseconds latency.

Modern production technologies in the automobile industry must become more flexible in order to fulfil individual customer requirements.

Im Focus: Sharp images with flexible fibers

An international team of scientists has discovered a new way to transfer image information through multimodal fibers with almost no distortion - even if the fiber is bent. The results of the study, to which scientist from the Leibniz-Institute of Photonic Technology Jena (Leibniz IPHT) contributed, were published on 6thJune in the highly-cited journal Physical Review Letters.

Endoscopes allow doctors to see into a patient’s body like through a keyhole. Typically, the images are transmitted via a bundle of several hundreds of optical...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Munich conference on asteroid detection, tracking and defense

13.06.2018 | Event News

2nd International Baltic Earth Conference in Denmark: “The Baltic Sea region in Transition”

08.06.2018 | Event News

ISEKI_Food 2018: Conference with Holistic View of Food Production

05.06.2018 | Event News

 
Latest News

Could this material enable autonomous vehicles to come to market sooner?

20.06.2018 | Materials Sciences

Innovative autonomous system for identifying schools of fish

20.06.2018 | Information Technology

Controlling robots with brainwaves and hand gestures

20.06.2018 | Information Technology

VideoLinks
Science & Research
Overview of more VideoLinks >>>